DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Zhu FC, Li YH, Guan XH. et al
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet (London, England) 2020;
395: 1845-1854 . doi:10.1016/S0140-6736(20)31208-3
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.